2021 Revenues ($USD) : $870,463,000
2021 R&D spend : $32,857,000
2021 Number of Employees : 2,708
Fiscal Year End : 3/28/2021
Key People : Christopher Simon, president and CEO; Michelle Basil, EVP, general counsel; William Burke, EVP, CFO; Anila Lingamneni, EVP, CTO; Kerri DiPietro, SVP, global quality assurance; Josep Lluis Llorens, EVP, global manufacturing and supply chain; Laurie Miller, SVP, CHRO; Chad Nikel, president, global plasma and blood center; Kevin O'Kelly-Lynch, SVP, global business services; Stewart Strong, president, global hospital.

About the company: In 1953, Allen “Jack” Latham recognized the need for improved blood processing systems at Harvard Medical School. Eighteen years later, Haemonetics was born in Natick, Massachusetts, with its sights set on improving the safety and quality of blood supply. Today, the company employs nearly 2,000 people with offices located in 16 countries, led by President and CEO Christopher Simon. Haemonetics markets its products, which include blood collection devices, plasma collection devices, venous vascular closure systems and more, across more than 50 countries around the globe. –SW